dismiss

Garage Sale Auctions: Over 700 lots are available for a LIMITED TIME ONLY...starting at just $1! Click here to bid now!

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Oncology Homepage

Researchers develop AI approach for high-risk clinical tumor volumes Assisting low- and middle-income countries that lack contouring expertise

Dr. Benjamin Movsas American Radium Society Names president-elect

Tennessee governor vetoes state employee proton therapy coverage Would require PT to be covered under the same aggregate amount as IMRT

Hospital in Italy performs radiosurgery with Brainlab's Elements Spine SRS software Automatically plans treatments for complex parts of the body

AI approach used to study Mars now assessing tumor response to therapies Could reduce sample sizes and accelerate process for approval of cancer therapies

European medical center first to perform linac-based MR-guided RT using on-table adaptation Made possible with ViewRay's MRIdian Linac

Thermal imaging in development could provide real-time ablation views Taking guesswork and additional imaging out of the equation

PPI to purchase Elekta MR-linac systems for £25 million Will install at five cancer centers across the UK

Dr. Nancy P. Mendenhall Medical Director of UF Health Proton Therapy selected by University of Florida as 2018 Clinical Science Researcher of the Year

ViewRay showcases enhancements to MRIdian Linac system at ESTRO Will offer MR pulse sequencing capabilities

Based on one of largest studies
comparing digital and
conventional approaches

Philips IntelliSite Pathology Solution gets FDA clearance for primary diagnostic use

by Lauren Dubinsky , Senior Reporter
Royal Philips announced on Wednesday that the FDA cleared its Philips IntelliSite Pathology Solution (PIPS) for primary diagnostic use. It's the first whole-slide imaging system that can be used to review and interpret digital surgical pathology slide prepared from biopsied tissue.

"[PIPS] allows pathologists to simplify access to histopathology information and work more efficiently," Russ Granzow, general manager of Philips Digital Pathology Solution, told HCB News. "The pathologists will have the agility to view digital images and aim to extend collaboration with peers, with the aim of increasing diagnostic confidence."

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



As cancer becomes more prevalent, pathologists are under pressure to meet the demand. They have to work as efficiently and effectively as possible to analyze the complex data that's used to design personalized treatments.

PIPS is composed of an ultra-fast pathology slide scanner, an image management system and display monitor. It also comes with advanced software tools to manage the scanning, storage, presentation, reviewing and information sharing processes.

With this solution, pathologists can read tissue slides digitally to make a diagnosis, instead of using a conventional light microscope to look directly at the tissue sample mounted on a glass slide.

"Because the system digitizes slides that would otherwise be stored in physical files, it also provides a streamlined slide storage and retrieval system that may ultimately help make critical health information available to pathologists, other health care professionals and patients faster," Alberto Gutierrez, director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health, said in a statement.

The agency evaluated data from a clinical study that involved about 2,000 surgical pathology cases. It was one of the largest studies that directly compared the use of digital pathology to conventional optical microscopes.

Sixteen pathologists at Cleveland Clinic, University of Virginia, Miraca Life Sciences and Advanced Pathology Associates performed about 16,000 reads of the cases. The results showed that the diagnoses made using PIPS were comparable to those made using the conventional method.

Previously, PIPS was only approved by the FDA to be used as an aid to the pathologist when detecting HER2 expression in breast cancer. It's now been expanded for primary diagnostic use.

Digital pathology has been a major focus for Philips in recent years. In June 2016, the company acquired PathXL's digital pathology portfolio. More recently in March, they partnered with a developer of artificial intelligence technology for pathology called PathAI.

In the same month, Philips introduced new additions to its pathology solutions portfolio at the 2017 United States and Canadian Academy of Pathology Annual Meeting. That includes research applications called TissueMark and Xplore, and applications for semi-quantification of breast IHC markers.

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED